10-K: Veeco Navigates Merger, Reports Mixed 2025 Results

Sentiment:

Annual Report


Veeco Instruments Inc. reported a 7% decline in net sales and a 52% drop in net income for 2025, while advancing its merger with Axcelis Technologies and seeing strong growth in its Semiconductor and Scientific & Other markets.

Delay expectedThe planned merger with Axcelis Technologies, Inc. is subject to certain closing conditions, including regulatory approvals, which may impose unexpected delays in completion.The Merger Agreement provides for automatic extensions of the termination date until as late as June 30, 2027, under certain conditions with respect to regulatory approvals, indicating potential for prolonged delays.Two laser annealing systems shipped to customers in China were detained at the Port of San Francisco pending review by U.S. Customs and Border Protection, causing temporary shipping delays, although they were subsequently released.
Worse than expectedNet sales decreased by 7% year-over-year, indicating a decline in overall business activity.Net income decreased by 52% year-over-year, reflecting a significant drop in profitability.Gross profit and gross margins both declined, suggesting pressure on pricing, product mix, and costs.Operating income decreased by 47%, highlighting reduced operational efficiency or market challenges.Significant sales declines in key segments like Data Storage (-60%) and Compound Semiconductor (-23%) contributed to the overall negative performance.

Summary

  • Net sales for the year ended December 31, 2025, decreased by 7% to $664.3 million from $717.3 million in 2024.
  • Net income for 2025 was $35.4 million, a significant decrease from $73.7 million in 2024.
  • Gross profit declined by 13% to $265.4 million in 2025, with gross margins decreasing from 42% to 40% due to unfavorable product mix and higher production/tariff-related costs.
  • Operating income fell by 47% to $35.7 million in 2025 compared to $67.0 million in 2024.
  • The company's backlog increased to $554.9 million at December 31, 2025, up from $409.6 million at December 31, 2024.
  • The Semiconductor market segment grew by 2% in 2025, accounting for 72% of total revenue, driven by Laser Annealing and Advanced Packaging.
  • The Compound Semiconductor market saw a 23% decline in sales, while Data Storage sales decreased by 60%.
  • Sales in the Scientific & Other market increased by 20% in 2025.
  • Geographically, sales decreased in the U.S. (-38%), EMEA (-18%), and China (-29%), but increased significantly in the Rest of APAC region (+41%).
  • Merger-related costs of $8.9 million were incurred in 2025 in connection with the proposed merger with Axcelis Technologies, Inc.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with a cautious sentiment. While the company is making strategic advancements in key growth areas like AI-related semiconductor technologies and has a growing backlog, the significant declines in net sales, net income, and gross profit for 2025, coupled with ongoing merger uncertainties and geopolitical trade risks, present considerable headwinds.

Positives

  • Backlog significantly increased to $554.9 million at year-end 2025, up from $409.6 million in 2024, indicating future revenue potential.
  • Semiconductor market revenue grew by 2% in 2025, driven by Laser Annealing and Advanced Packaging, with strong demand from AI-related applications.
  • Successfully shipped a Laser Spike Annealing (LSA) system to a second Tier 1 memory customer for advanced DRAM R&D evaluation, expanding market penetration.
  • Achieved steady year-over-year growth in the Advanced Packaging business, securing multiple orders for wet processing and lithography systems from leading foundries.
  • Received multiple orders in the Compound Semiconductor market for new Propel 300mm GaN on Silicon and Lumina+ Arsenide Phosphide platforms, expected to drive H2 2026 revenue growth.
  • New orders in the Data Storage market for ion beam and wet processing equipment, driven by cloud and AI data centers, are expected to boost H2 2026 revenue.
  • Continued investment in next-generation technologies, with Nanosecond Annealing (NSA) and Ion Beam Deposition 300 (IBD300) systems under evaluation at Tier 1 customers, positioning for future SAM growth.
  • Net cash provided by operating activities increased to $69.5 million in 2025 from $63.8 million in 2024.
  • Cash and cash equivalents increased to $163.5 million in 2025 from $145.6 million in 2024, and short-term investments also grew.
  • Employee voluntary turnover rate of 7.6% and average tenure of over 8 years compare favorably to industry benchmarks, reflecting strong employee engagement and retention.

Negatives

  • Total net sales decreased by 7% in 2025 compared to 2024, primarily due to declines in Data Storage and Compound Semiconductor markets.
  • Net income decreased by 52% to $35.4 million in 2025 from $73.7 million in 2024.
  • Gross profit decreased by 13% and gross margin declined from 42% to 40% in 2025, attributed to unfavorable product mix and higher production/tariff costs.
  • Operating income decreased by 47% in 2025.
  • Significant sales declines were observed in the Data Storage (-60%) and Compound Semiconductor (-23%) markets.
  • Sales in China decreased by 29% in 2025, impacted by U.S. trade policies and export controls.
  • The company incurred $8.9 million in merger-related costs in 2025.
  • The 2024 asset impairment charge of $28.1 million related to Epiluvac's SiC technology indicates a failure to meet market penetration expectations for an acquired asset.
  • The company has a concentrated customer base, with the top 10 customers accounting for 68% of net accounts receivable, posing a risk if these relationships are disrupted.

Risks

  • Changes in U.S. and foreign trade policies, including heightened tariffs and ongoing trade disputes between the U.S. and China, could adversely affect business, results of operations, and financial condition.
  • Inability to obtain required export licenses for product sales, particularly to customers in China, could lead to shipping delays, inhibited technical discussions, and negative impacts on sales opportunities.
  • Unfavorable market conditions, including reduced demand, asset impairments, increased price competition, and supply chain disruptions, could negatively impact sales, revenue, margins, and profitability.
  • Operating in industries characterized by rapid technological change requires continuous product enhancement and development, with failure to predict transitions or allocate resources effectively posing a risk.
  • Disruptions in information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm.
  • Inability to effectively enforce and protect intellectual property rights, or claims of infringement by others, could lead to substantial costs and jeopardize customer/supplier relationships.
  • Tightening credit markets, including increases in interest rates, could prevent customers from obtaining financing, leading to decreased product orders and pricing pressures.
  • Exposure to foreign currency exchange risks due to global operations, which hedging activities may not always adequately mitigate.
  • Potential for asset impairment charges on goodwill and intangible assets if fair values fall below carrying amounts, as seen with the Epiluvac acquisition.
  • The planned merger with Axcelis Technologies, Inc. is subject to closing conditions, including regulatory approvals, which may cause delays or termination, adversely affecting stock price and business.
  • The pendency of the merger could divert management attention, make employee retention difficult, and restrict the company from pursuing attractive business opportunities.
  • Current stockholders will have a reduced ownership interest and voting power in the combined company after the merger.
  • The price of common shares is volatile and could decrease due to macroeconomic conditions, product performance issues, failure to meet analyst estimates, and litigation.
  • Inability to attract, retain, and motivate employees, particularly skilled technical personnel, could materially adversely affect the business.
  • Non-compliance with environmental, health, and safety regulations, including those related to carbon emissions and climate change, could result in significant liabilities, fines, and reputational harm.
  • ESG goals and strategies could be costly to implement, and failures to comply with evolving sustainability requirements could impact product demand and reputation.
  • Anti-takeover measures adopted by the company may make an acquisition more difficult, potentially not aligning with shareholder interests.

Future Outlook

The company anticipates long-term growth in the semiconductor industry, driven by secular trends such as artificial intelligence, high-performance computing, mobile connectivity, and automotive electrification, further supported by government investments. This growth, coupled with increasing technological complexity, is expected to drive long-term growth in wafer fabrication equipment (WFE) spending, benefiting semiconductor capital equipment providers. Specifically, the company expects growth in leading-edge investment driven by new nodes and AI-related demand, including Gate-All-Around nodes, High-Bandwidth Memory, and 3D packaging for AI. Revenue growth for 2026, particularly in the second half, is projected from new orders in the Compound Semiconductor and Data Storage markets.

Management Comments

  • "Veeco executed well during 2025, and accomplished a number of milestones."
  • "Penetrating the annealing market in the memory space, with our LSA system is an important growth opportunity."
  • "Our growth strategy remains predominately focused on advanced node logic and memory customers."
  • "Nanosecond annealing provides Veeco with an opportunity to expand our laser annealing SAM for new advanced node logic and memory applications, including low thermal budget anneals for Gate-All-Around transistors and advanced 3D devices."
  • "Our product roadmap is well positioned as the industry adopts next-generation High-NA EUV lithography, and we are expanding our EUV related business to EUV pellicles."
  • "We believe these inflection points position us well to capture our largest SAM growth opportunities in 2026 and beyond."

Industry Context

StockSavvy.ai notes that Veeco's performance in 2025 reflects a mixed industry landscape. While the overall semiconductor market is estimated by Gartner to have grown to $770 billion, Veeco experienced a decline in total net sales, primarily due to significant downturns in the Data Storage and Compound Semiconductor markets. However, the company's strategic focus on advanced logic and memory, particularly in AI-related applications, aligns with broader industry trends of increasing demand for high-performance computing and advanced packaging. The strong growth in the Semiconductor segment and the evaluation of next-generation annealing and deposition systems position Veeco to capitalize on future industry inflections, despite current market cyclicality and geopolitical trade tensions impacting sales in regions like China.

Comparison to Industry Standards

  • The semiconductor industry sales are estimated to have increased year-over-year in 2025 to approximately $770 billion, according to Gartner, while Veeco's overall net sales decreased by 7%. This suggests Veeco's performance lagged the broader industry growth in 2025.
  • Veeco's voluntary turnover average of approximately 7.6% and average employee tenure of more than 8 years compare favorably to general industry benchmarks, indicating strong employee engagement and retention within the company.
  • The company's investment in next-generation technologies like Nanosecond Annealing (NSA) and Ion Beam Deposition 300 (IBD300) for advanced logic and memory applications, including Gate-All-Around transistors and 3D devices, positions it to compete with leading-edge equipment providers like Applied Materials and Screen Semiconductor Solutions in critical technology transitions.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and DirectorNAWilliam J. Miller, Ph.D.NAWill continue as a director of the combined company after the merger, eligible for non-employee director compensation.
DirectorNARichard A. DamoreNAChairman of the Board.
DirectorNAKathleen A. BaylessNANA
DirectorNASujeet Chand, Ph.D.NANA
DirectorNAGordon HunterNANA
DirectorNAKeith D. JacksonNANA
DirectorNALena Nicolaides, Ph.D.NANA
DirectorNAMary Jane RaymondNANA
DirectorNAThomas St. DennisNANA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Merger Agreement ApprovalVeeco's board of directors (excluding one recused independent director also on Axcelis' board) approved the Agreement and Plan of Merger with Axcelis Technologies, Inc. on September 30, 2025. Stockholders of both companies approved it on February 6, 2026.2025-09-30This approval is a critical step towards the merger, which will result in Veeco becoming a wholly-owned subsidiary of Axcelis, significantly altering its corporate structure and governance under Axcelis' control.
Loan and Security Agreement AmendmentThe Loan and Security Agreement was amended on September 30, 2025 (Fifth Amendment) to modify definitions of 'Changes of Control' and 'Merger, Consolidation and Sale of Assets' covenants following the merger announcement.2025-09-30These amendments ensure the existing debt facilities are aligned with the terms of the pending merger, mitigating potential default risks related to the change of control.
Cybersecurity OversightCybersecurity risk management is integrated into the company's enterprise risk management (ERM) approach, with oversight assigned to the full Board and the Audit Committee. Quarterly updates are provided by management, including the Chief Information Security Officer.OngoingThis structured oversight enhances the company's ability to identify, prevent, and mitigate cybersecurity threats, protecting intellectual property and sensitive information, which is crucial in a technology-driven industry.
Anti-Takeover MeasuresThe company has adopted measures such as blank check preferred stock, a classified board, super-majority requirements for certain bylaws amendments, limits on director numbers, and directors removable only for cause. It is also subject to Section 203 of Delaware law.NAThese measures may delay, defer, or prevent a takeover or other change in control, potentially limiting shareholder ability to influence company policies or accept alternative acquisition proposals.

Legal Proceedings

  • The company is involved in various legal proceedings arising in the normal course of business, but does not believe their ultimate resolution will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Stakeholder Impact

  • **Shareholders:** Will experience a reduced ownership interest and voting power in the combined company (approximately 41.6% of Axcelis common stock) after the merger. The value of their consideration will fluctuate with Axcelis' stock price. The 2025 Notes were settled by issuing 1.1 million shares of common stock, and the 2027 Notes were settled by issuing 1.6 million shares and $5.4 million cash.
  • **Employees:** The merger may affect the ability to attract, retain, and motivate key personnel due to uncertainty about future roles and integration processes. However, the company's strong employee engagement and retention metrics (7.6% voluntary turnover, >8 years average tenure) are positive. Certain executives, including the CEO, will continue as directors of the combined company and are entitled to severance payments and accelerated equity awards in case of involuntary termination related to a change of control.
  • **Customers:** May delay or defer decisions concerning business relationships due to the pending merger. The company's concentrated customer base (top 10 customers account for 68% of net accounts receivable) makes it vulnerable to changes in these relationships. Trade policy changes and export controls, particularly with China, have impacted and may continue to impact the ability to sell and service products, potentially leading to order cancellations or renegotiations.
  • **Suppliers:** The company relies on a limited number of suppliers, some sole-source, and outsourcing partners. Disruptions in their performance or supply chain could impact the company's ability to meet customer demand and increase costs. The company had $150.8 million in purchase commitments at year-end 2025, partially offset by $9.8 million in supplier deposits.
  • **Creditors:** The 2029 Convertible Senior Notes will be assumed by Axcelis. The company maintains an undrawn $250 million revolving credit facility, providing liquidity. Debt facilities contain covenants that could limit financial flexibility, and failure to comply could accelerate debt obligations.

Next Steps

  • Complete the merger with Axcelis Technologies, Inc., expected in the second half of 2026, pending regulatory approvals.
  • Continue evaluation of Nanosecond Annealing (NSA) systems at two Tier 1 logic customers.
  • Continue evaluation of Ion Beam Deposition 300 (IBD300) systems at two DRAM memory customers into 2026.
  • Drive revenue growth in the Compound Semiconductor market in 2026, principally in the second half, from new Propel 300mm GaN on Silicon and Lumina+ Arsenide Phosphide platforms.
  • Drive revenue growth in the Data Storage market in 2026, principally in the second half, from ion beam and wet processing equipment orders for cloud and AI data centers.
  • Monitor and adapt to evolving U.S. and foreign trade policies, export controls, and geopolitical tensions, particularly concerning sales to China.
  • Assess and monitor potential impacts and developments from Pillar Two tax requirements and the One Big Beautiful Bill Act (OBBBA).

Key Dates

DateDescription
2023-01-31Acquisition of Epiluvac AB, a manufacturer of SiC-based CVD epitaxy systems.
2023-05-19Completion of a private offering of $230.0 million of 2.875% convertible senior notes due 2029.
2024-12-31Effective date for the adoption of ASU 2023-09 Improvements to Income Tax Disclosures (Topic 740) on a retrospective basis.
2024-Q4Recorded a non-cash impairment charge of $28.1 million related to intangible assets of SiC technology acquired from Epiluvac due to market penetration not meeting expectations.
2025-01-15Remaining principal amount of $26.5 million 2025 Notes matured and were settled through the issuance of 1.1 million shares of common stock.
2025-05-15Remaining principal amount of $25.0 million 2027 Notes were settled in a private transaction for 1.6 million shares of common stock and $5.4 million in cash.
2025-06-16Fourth Amendment to Loan and Security Agreement, increasing the revolving credit facility to $250 million and extending maturity to June 16, 2030.
2025-06-30Effective date for the prospective adoption of ASU 2024-04, Debt – Debt with Conversion and Other Options (Subtopic 470-20).
2025-07-04Enactment of the One Big Beautiful Bill Act (OBBBA) providing significant corporate tax reforms.
2025-09-30Entered into an Agreement and Plan of Merger with Axcelis Technologies, Inc. and Victory Merger Sub, Inc.
2025-Q4Two laser annealing systems shipped to customers in China were detained at the Port of San Francisco, but subsequently released and recognized into revenue.
2025-12-31Fiscal year end for the annual report.
2026-02-06Stockholders of Veeco and Axcelis Technologies, Inc. approved the Merger Agreement.
2026-02-25Date of the audit report by KPMG LLP and filing date of the 10-K.
2026-H2Expected closing period for the merger with Axcelis Technologies, Inc., pending regulatory approvals.
2026-06-08Earliest date the company may redeem all or any portion of the outstanding 2029 Notes at its option.
2026-09-30Initial outside date for termination of the Merger Agreement if the merger has not occurred.
2027-06-30Latest possible extended termination date for the Merger Agreement under certain conditions related to regulatory approvals.
2029-02-01Date from which holders may convert their 2029 Notes at any time, regardless of other circumstances.
2029-03-02Springing maturity date for the Credit Facility upon the occurrence of certain liquidity events.
2029-06-01Maturity date for the 2.875% Convertible Senior Notes.
2030-06-16Maturity date for the revolving credit facility.

Recommendation

hold

The filing presents a mixed picture, warranting a 'hold' recommendation. While Veeco is strategically positioned in high-growth areas like AI-related semiconductor manufacturing and has a strong backlog, the significant year-over-year declines in net sales, net income, and gross profit are concerning. The pending merger with Axcelis introduces both potential synergies and integration risks, along with a reduction in Veeco shareholders' ownership and voting power. Geopolitical trade tensions and customer concentration also pose ongoing risks. The long-term growth potential in advanced semiconductor nodes and AI applications is positive, but current financial performance and merger-related uncertainties suggest a cautious stance until more clarity emerges on the combined entity's operational and financial trajectory.

Keywords

Semiconductor Equipment, Advanced Packaging, Laser Annealing, Ion Beam Deposition, MOCVD, Compound Semiconductor, Data Storage, AI Chips, High-Performance Computing, 5G Networks, EUV Lithography, Axcelis Merger, SEC Filing, 10-K, Financial Results, Technology Manufacturing, Global Trade Risks

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.